menu

Protecting Adults from Pneumococcal Disease through Vaccination

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Protecting Adults from Pneumococcal Disease through Vaccination

0.50 credits
30 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.50 credits
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
  • Overview

    Pneumococcal disease can cause pneumonia, meningitis, and sepsis, and can be a serious complication of influenza. Pneumococcal disease is serious and can be deadly; in the US, more than 150,000 adults are hospitalized with pneumococcal pneumonia each year, and about 1 in 20 individuals who get pneumococcal pneumonia will die. According to the 2017 National Health Interview Survey, pneumococcal vaccination coverage among adults age 65 years and older was 69%, well below US public health goals. The changing recommendations for pneumococcal vaccination in adults can make the vaccination assessment process challenging for healthcare professionals. This activity is based on the latest CDC recommendations and includes practical strategies to implement pneumococcal vaccination.

  • Disclosure of Conflicts of Interest

    • Marla Dalton (NFID Staff) owns stock, stock options, patent, or other intellectual property from Merck & Co., Inc.
    • William Schaffner (NFID Medical Director) served as an advisor or consultant for VBI Vaccines, Inc.

    All of the relevant financial relationships listed for these individuals have been mitigated

    All other individuals in a position to control the content of this activity have no relevant financial relationships with ineligible companies to disclose

  • Target Audience

    Healthcare professionals (physicians, pharmacists, nurses, nurse practitioners, physician assistants, and other public health professionals) working in a variety of practice settings

  • Learning Objectives

    At the conclusion of the activity, participants will be able to:

    • Describe current US recommendations for pneumococcal vaccination
    • Discuss strategies to implement pneumococcal vaccination in practice
  • Accreditation and Credit Designation Statements

    The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    NFID designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an unrestricted educational grant from Pfizer Inc.
    NFID policies restrict funders from controlling program content. 

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Recommended
Details
Presenters
Related
  • Overview

    Pneumococcal disease can cause pneumonia, meningitis, and sepsis, and can be a serious complication of influenza. Pneumococcal disease is serious and can be deadly; in the US, more than 150,000 adults are hospitalized with pneumococcal pneumonia each year, and about 1 in 20 individuals who get pneumococcal pneumonia will die. According to the 2017 National Health Interview Survey, pneumococcal vaccination coverage among adults age 65 years and older was 69%, well below US public health goals. The changing recommendations for pneumococcal vaccination in adults can make the vaccination assessment process challenging for healthcare professionals. This activity is based on the latest CDC recommendations and includes practical strategies to implement pneumococcal vaccination.

  • Disclosure of Conflicts of Interest

    • Marla Dalton (NFID Staff) owns stock, stock options, patent, or other intellectual property from Merck & Co., Inc.
    • William Schaffner (NFID Medical Director) served as an advisor or consultant for VBI Vaccines, Inc.

    All of the relevant financial relationships listed for these individuals have been mitigated

    All other individuals in a position to control the content of this activity have no relevant financial relationships with ineligible companies to disclose

  • Target Audience

    Healthcare professionals (physicians, pharmacists, nurses, nurse practitioners, physician assistants, and other public health professionals) working in a variety of practice settings

  • Learning Objectives

    At the conclusion of the activity, participants will be able to:

    • Describe current US recommendations for pneumococcal vaccination
    • Discuss strategies to implement pneumococcal vaccination in practice
  • Accreditation and Credit Designation Statements

    The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    NFID designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an unrestricted educational grant from Pfizer Inc.
    NFID policies restrict funders from controlling program content. 

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Schedule22 May 2022
Webpack App